These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11328874)

  • 1. Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.
    Mir AA; Lockett TJ; Hendry P
    Nucleic Acids Res; 2001 May; 29(9):1906-14. PubMed ID: 11328874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of hammerhead ribozymes containing non-nucleotidic linkers.
    Thomson JB; Tuschl T; Eckstein F
    Nucleic Acids Res; 1993 Dec; 21(24):5600-3. PubMed ID: 7506829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of intermolecular cleavage by hammerhead ribozymes.
    Fedor MJ; Uhlenbeck OC
    Biochemistry; 1992 Dec; 31(48):12042-54. PubMed ID: 1280996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.
    Grassi G; Forlino A; Marini JC
    Nucleic Acids Res; 1997 Sep; 25(17):3451-8. PubMed ID: 9254703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonuclease H attack of leukaemic fused transcripts AML1-MTG8 (ETO) by DNA/RNA chimeric hammerhead ribozymes.
    Kozu T; Sugio Y; Fukuyama T; Sueoka E; Otsuka T; Akagi K
    Genes Cells; 2000 Aug; 5(8):637-47. PubMed ID: 10947849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ultraviolet crosslink in the hammerhead ribozyme dependent on 2-thiocytidine or 4-thiouridine substitution.
    Wang L; Ruffner DE
    Nucleic Acids Res; 1997 Nov; 25(21):4355-61. PubMed ID: 9336468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
    Murray JB; Dunham CM; Scott WG
    J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evolution of the hammerhead ribozyme to a purine-specific ribozyme using mutagenic PCR with two nucleotide analogues.
    Kore AR; Vaish NK; Morris JA; Eckstein F
    J Mol Biol; 2000 Sep; 301(5):1113-21. PubMed ID: 10966809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing accessible sites for ribozymes on human acetylcholinesterase RNA.
    Birikh KR; Berlin YA; Soreq H; Eckstein F
    RNA; 1997 Apr; 3(4):429-37. PubMed ID: 9085849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and thermodynamics of intermolecular catalysis by hairpin ribozymes.
    Hegg LA; Fedor MJ
    Biochemistry; 1995 Dec; 34(48):15813-28. PubMed ID: 7495813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.
    Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes.
    Hendry P; McCall MJ
    Nucleic Acids Res; 1995 Oct; 23(19):3928-36. PubMed ID: 7479038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phosphorothioate and 2-amino groups in hammerhead ribozymes on cleavage rates and Mg2+ binding.
    Koizumi M; Ohtsuka E
    Biochemistry; 1991 May; 30(21):5145-50. PubMed ID: 2036380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.
    Pieken WA; Olsen DB; Benseler F; Aurup H; Eckstein F
    Science; 1991 Jul; 253(5017):314-7. PubMed ID: 1857967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.